Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use"
NCT03214094 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1119
Last updated 2020-03-11
Summary
The purpose of this survey is to investigate the safety and effectiveness of long-term administration of vonoprazan tablets for up to 12 months in the routine clinical setting in patients receiving low-dose aspirin.
Conditions
- Gastric or Duodenal Ulcers
Interventions
- DRUG
-
Vonoprazan
Vonoprazan tablets
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Study Director · Takeda
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-09-01
- Primary Completion
- 2019-02-28
- Completion
- 2019-02-28
Countries
- Japan
Study Locations
More Related Trials
-
A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy
NCT01568398 ·Status: COMPLETED ·Phase: PHASE3
-
Cardio-cerebrovascular Disease and Aspirin Ulcer Relapse Evaluation
NCT01051388 ·Status: COMPLETED ·Phase: PHASE3
-
Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety
NCT02679508 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)
NCT01452750 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)
NCT01456260 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers
NCT00762359 ·Status: TERMINATED ·Phase: PHASE3
-
Nexium Capsules LDA Specific Clinical Experience Investigation
NCT01729182 ·Status: COMPLETED
-
Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose Aspirin
NCT01069939 ·Status: COMPLETED ·Phase: PHASE3
-
Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin
NCT02423187 ·Status: COMPLETED
-
Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection
NCT03050359 ·Status: COMPLETED ·Phase: PHASE3
-
Lansoprazole Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]
NCT02151786 ·Status: COMPLETED
-
Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers
NCT00960869 ·Status: COMPLETED ·Phase: PHASE3
-
A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy
NCT01568385 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection
NCT03050307 ·Status: COMPLETED ·Phase: PHASE3
-
Takepron Intravenous 30 mg Specified Drug-use Survey [Acute Stress Ulcer and Acute Gastric Mucosal Lesions]
NCT02170207 ·Status: COMPLETED
-
A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers
NCT00961350 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)
NCT01397448 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase 3 Study to Evaluate the Acid-Inhibitory Effect of Multiple Oral Doses of Vonoprazan (TAK-438)
NCT02037477 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety, Efficacy of Tegoprazan for the Prevention of PUD in Patients on Treatment With NSAIDs
NCT04840550 ·Status: UNKNOWN ·Phase: PHASE3
-
Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)
NCT01398410 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Comparison of Two Therapeutic Strategies for the Treatment of Aspirin-associated Peptic Ulcers
NCT01353144 ·Status: COMPLETED ·Phase: PHASE4
-
Ulcer Prevention II
NCT00629928 ·Status: COMPLETED ·Phase: PHASE3
-
Rabeprazole Protection of Aspirin Induced Gastric Damage.
NCT00220857 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Vonoprazan Versus Intravenous Proton Pump Inhibitors for Prevention of Rebleeding in High Risk Peptic Ulcers Bleeding After Successful Endoscopic Hemostasis
NCT05005910 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users
NCT02342470 ·Status: COMPLETED ·Phase: PHASE2